返回ChemicalBook首页>CAS数据库列表>2227372-56-5

2227372-56-5

中文名称 (Z)-1-[2-CHLORO-2-(2,4-DICHLOROPHENYL)ETHENYL]-1H-1,2,4-TRIAZOLE HYDROCHLORIDE
英文名称 (Z)-1-[2-CHLORO-2-(2,4-DICHLOROPHENYL)ETHENYL]-1H-1,2,4-TRIAZOLE HYDROCHLORIDE
CAS 2227372-56-5
分子式 C10H7Cl4N3
分子量 310.99
MOL 文件 2227372-56-5.mol
更新日期 2024/06/03 12:51:12
2227372-56-5 结构式 2227372-56-5 结构式

基本信息

英文别名
LORECLEZOLE HYDROCHLORIDE
(Z)-1-[2-CHLORO-2-(2,4-DICHLOROPHENYL)ETHENYL]-1H-1,2,4-TRIAZOLE HYDROCHLORIDE

物理化学性质

溶解度Soluble to 5 mM in DMSO with gentle warming and to 5 mM in ethanol with gentle warming

安全数据

危险性符号(GHS)
GHS07
警示词警告
危险性描述H302-H315-H319-H335

常见问题列表

生物活性
Loreclezole hydrochloride 是一种抗癫痫化合物,是选择性的 GABAA 受体 的调节剂,是β2 或β3亚单位包含受体的正向变构调节剂。
靶点

GABA A receptor.

体内研究

Loreclezole (10, 25, 50 or 75 mg/kg, i.p. 60 min before measurement of seizure threshold ) results in a dosedependent rise in seizure threshold as measured by the dose of pentylenetetrazolrequired to produce a convulsion 60 min later. Loreclezole also has the least effect on loss of muscle tone as measured by the “pull-up” test.

Animal Model: Adult male Lister Hooded rats.
Dosage: 10, 25, 50 or 75 mg/kg.
Administration: IP, 60 min before measurement of seizure threshold.
Result: Resulted in a dosedependent rise in seizure threshold as measured by the dose of pentylenetetrazolrequired to produce a convulsion 60 min later.
"2227372-56-5" 相关产品信息